Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

Paul Monagle, Anthonie W. A. Lensing*, Kirstin Thelen, Ida Martinelli, Christoph Male, Amparo Santamaria, Elena Samochatova, Riten Kumar, Susanne Holzhauer, Paola Saracco, Paolo Simioni, Jeremy Robertson, Gernot Grangl, Jacqueline Halton, Phillip Connor, Guy Young, Angelo C. Molinari, Ulrike Nowak-Goettl, Gili Kenet, Stefanie KapsaStefan Willmann, Akos F. Pap, Michael Becka, Teresa Twomey, Jan Beyer-Westendorf, Martin H. Prins, Dagmar Kubitza, EINSTEIN-Jr Phase 2 Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

INIS